HomeNewsBusinessBharat Highways InvIT the first publicly listed InvIT with only HAM assets: Management

Bharat Highways InvIT the first publicly listed InvIT with only HAM assets: Management

The public issue of Bharat Highways Infrastructure Investment Trust (InvIT) was subscribed 8.02 times as investors bought 82.53 crore units against an offer size of 10.3 crore units

March 12, 2024 / 15:05 IST
Story continues below Advertisement
Bharat Highways InvIT IPO
During the book building process, the projected IRR is estimated to be 350-400 BPS higher than 12 or 13-year AAA paper, making it an exceptional asset class, said the company’s CEO, Amit Kumar Singh

Bharat Highways InvIT is the first publicly listed InvIT in India with all hybrid annuity model (HAM) assets consolidated under one entity. The company hit the primary market with a Rs 2,500-crore offering, the biggest so far in 2024.

The public issue of Bharat Highways Infrastructure Investment Trust (InvIT) was subscribed 8.02 times as investors bought 82.53 crore units against an offer size of 10.3 crore units. Despite this, it staged silent debut and listed with 1.1 percent premium.

Story continues below Advertisement

The company gets fixed annuity income from NHAI. During the book building process, the projected IRR is estimated to be 350-400 BPS higher than 12 or 13-year AAA paper, making it an exceptional asset class, the company’s CEO, Amit Kumar Singh, told Moneycontrol in an exclusive interview.

Edited excerpts follow:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show